Abiopharma

🔍 Wang Yanjun (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Sold 257 shares of Class A ordinary shares at $83.01 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 13,743.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 224 shares of Class A ordinary shares at $84.24 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 13,519.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 319 shares of Class A ordinary shares at $84.99 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 13,200.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 800 shares of Class A ordinary shares at $86.13 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 12,400.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-04-30 | Code: H | shares_owned_after: 1,222,842.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on September 4, 2025.
• F2: Represents the weighted average price of shares sold at prices that ranged from $82.53 to $83.52. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $83.54 to $84.52.
• F4: Represents the weighted average price of shares sold at prices that ranged from $84.53 to $85.50.
• F5: Represents the weighted average price of shares sold at prices that ranged from $85.68 to $86.52.